<PAGE> 1
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
- - -------------------------------------------------------------------------------
SCHEDULE 13D/A
Under the Securities Exchange Act of 1934
(Amendment No. 1)
IVAX CORPORATION
(Name of Issuer)
Common Stock, Par Value $.10 per Share
(Title of Class of Securities)
46582310
(CUSIP Number)
Milan A. Sawdei, Esq.
Bergen Brunswig Corporation
4000 Metropolitan Drive
Orange, California 92868
Telephone: (714) 385-4000
(Name, Address and Telephone Number of
Person Authorized to Receive Notices and
Communications)
Copy to:
John A. Marzulli, Jr., Esq.
Shearman & Sterling
599 Lexington Avenue
New York, New York 10022
Telephone: (212) 848-4000
March 20, 1996
(Date of Event which Requires Filing of this Statement)
- - --------------------------------------------------------------------------------
If the filing person has previously filed a statement on Schedule 13G to report
the acquisition which is the subject of this Schedule 13D, and is filing this
schedule because of Rule 13d-1(b)(3) or (4), check the following box _.
<PAGE> 2
CUSIP No. 4652310
(1) Name of Reporting Person
S.S. or I.R.S. Identification No. of Above Person
BERGEN BRUNSWIG CORPORATION
I.R.S. IDENTIFICATION NO. 22-1444512
(2) Check the Appropriate Box if a Member of Group (See Instructions)
_ (a)
_ (b)
(3) SEC Use Only
(4) Sources of Funds (See Instructions) NOT APPLICABLE.
(5) Check if Disclosure of Legal Proceedings is Required Pursuant to
Items 2(d) or 2(e).
(6) Citizenship or Place of Organization NEW JERSEY
Number of (7) Sole Voting Power
Shares
Beneficially (8) Shared Voting Power 15,134,384
Owned by
Each (9) Sole Dispositive Power 30,177,342
Reporting
Person (10) Shared Dispositive Power
WITH
(11) Aggregate Amount Beneficially Owned by Each Reporting Person 45,311,726
(12) Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See
Instructions)
(13) Percent of Class Represented by Amount in Row (11)
29.9%
(14) Type of Reporting Person (See Instructions) CO
<PAGE> 3
Bergen Brunswig Corporation, a New Jersey corporation (the "Reporting
Person") hereby amends and supplements its Schedule 13D relating to the shares
of common stock, par value $.10 per share, of IVAX Corporation, a Florida
corporation (the "Issuer").
Item 4. PURPOSE OF TRANSACTION.
The Reporting Person has terminated the Agreement and Plan of Merger,
dated as of November 10, 1996 (the "Merger Ageement"), among BBI Healthcare
Corporation, a Delaware corporation, the Issuer, the Reporting Person, BBI-I
Sub, Inc., a Florida corporation, and BBI-B Sub, Inc., a New Jersey
corporation.
In connection with the termination of the Merger Agreement, the
Reporting Person intends to file a lawsuit against the Issuer in the United
States District Court for the Southern District of New York alleging,
among other things, various breaches of the Merger Agreement.
<PAGE> 4
2
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this Statement is true, complete and
correct.
March 20, 1997 BERGEN BRUNSWIG CORPORATION
By /S/ MILAN A. SAWDEI
Name: Milan A. Sawdei
Title: Executive Vice President,
Chief Legal Officer and
Secretary
